Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

CASI Pharmaceuticals Inc. (CASIF) vs VistaGen Therapeutics, Inc. (VTGN)

CASI Pharmaceuticals Inc. and VistaGen Therapeutics, Inc. are both Biotechnology companies. CASI Pharmaceuticals Inc. and VistaGen Therapeutics, Inc. are of similar size ($12.7M and $12.4M). VistaGen Therapeutics, Inc. grew revenue faster over the last twelve months: 287.2% against −27.4%. CASI Pharmaceuticals Inc. has the higher net margin (−232.0% vs −2,703.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, CASI Pharmaceuticals Inc. leads on 10 and VistaGen Therapeutics, Inc. on 6.

Valuation

Metric CASIF VTGN Biotechnology median
P/E n/m n/m 7.88
P/S 0.12 4.64 11.47
P/B n/m 0.47 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m 0.28 0.74
EV/Sales 1.81 (7.84) 10.73
Earnings yield (1,984.62%) (614.81%) (28.84%)
Free cash flow yield (3,717.40%) (538.13%) (23.03%)

Profitability

Metric CASIF VTGN Biotechnology median
Gross margin 48.65% 100.00% 65.16%
Operating margin (206.87%) (2,785.69%) 0.00%
Net margin (232.03%) (2,703.72%) 0.00%
Free cash flow margin (432.54%) (2,490.88%) 0.00%
Return on equity 0.00% (166.46%) (57.72%)
Return on assets 0.00% (129.22%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CASIF VTGN Biotechnology median
Revenue growth (TTM) (27.42%) 287.15% 5.64%
EPS growth (last fiscal year) (1.17%) (9.58%) —
Revenue growth, 5-year CAGR 6.47% 3.10% 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CASIF VTGN Biotechnology median
Debt to equity (0.34) 0.00 0.00
Current ratio 0.15 3.07 4.73
Net debt to EBITDA (0.43) 0.63 0.96

Dividend

Metric CASIF VTGN Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric CASIF VTGN Biotechnology median
Market cap 12.39m 12.65m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack